Details of the Drug
General Information of Drug (ID: DMSNL51)
Drug Name |
Oxfendazole
|
|||||
---|---|---|---|---|---|---|
Synonyms |
Oxfendazole; Fenbendazole sulfoxide; Synanthic; Systamex; OFDZ; Systemax; Repidose; Oxfendazolum; Oxfendazol; Synanthic (Veterinary); RS-8858; fenbendazole S-oxide; RS 8858; 5-Phenylsulfinyl-2-carbomethoxyaminobenzimidazole; Oxfendazol [INN-Spanish]; Oxfendazolum [INN-Latin]; UNII-OMP2H17F9E; HOE 8105; methyl [5-(phenylsulfinyl)-1H-benzimidazol-2-yl]carbamate; Oxfendazole [USAN:BAN:INN]; Methyl 5-(phenylsulfinyl)-2-benzimidazolecarbamate; Oxfendazole (USP/INN)
|
|||||
Structure | ||||||
3D MOL | 2D MOL | |||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 315.3 | ||||
Logarithm of the Partition Coefficient (xlogp) | 2.3 | |||||
Rotatable Bond Count (rotbonds) | 4 | |||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | |||||
Hydrogen Bond Acceptor Count (hbondacc) | 5 | |||||
Chemical Identifiers |
|
|||||
Cross-matching ID | ||||||
Combinatorial Drugs (CBD) | Click to Jump to the Detailed CBD Information of This Drug | |||||
Molecular Interaction Atlas of This Drug
Drug Transporter (DTP) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Off-Target (DOT) |
|
||||||||||||||||||||||||||
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||